- Investing Ideas
- /
- German Pharmaceuticals & Biotech Potentially Undervalued Companies
German Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 30, 2024
Companies with a Value score of at least 3, ordered by Value score
464 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
2DT | US$5.45 | 9.9% | 228.3% | US$1.8b | US$6.59 | PB94.4x | E92.6% | 0% | ||
PIG | US$30.49 | 8.6% | -9.7% | US$4.4b | US$37.08 | PB0.9x | E46.9% | 3.4% | ||
FUP | JP¥9.35 | 0.5% | 15.4% | JP¥38.7b | JP¥12.29 | PE7.6x | E-5.9% | 2.7% | ||
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | ||
MRK | €148.95 | -3.1% | -6.6% | €64.8b | €182.00 | PE22.9x | E9.9% | 1.5% | ||
G51 | HK$1.38 | 5.3% | -41.0% | HK$24.7b | HK$3.42 | PS3.8x | E92.5% | 0% | ||
IDP | US$200.80 | 8.7% | -28.8% | US$31.4b | US$267.30 | PE26.8x | E17.8% | n/a | ||
S2P | HK$0.64 | 4.9% | -38.5% | HK$13.9b | HK$1.02 | PE18x | E24.4% | 3.2% | ||
PHGN | €0.90 | 0.6% | -10.8% | €590.3m | €2.04 | PS2.6x | E52.9% | n/a | ||
4RY | HK$5.70 | 5.6% | 23.9% | HK$41.7b | HK$7.10 | PE19x | E10.8% | n/a | ||
APPH | €7.92 | 1.0% | 13.1% | €68.8m | €16.78 | PS1.9x | E79.9% | n/a | ||
R3X1 | US$1.46 | 4.1% | -72.1% | US$39.3m | US$17.91 | PS2.1x | E9.5% | n/a | ||
GIS | US$61.08 | -3.0% | -16.7% | US$82.2b | US$78.79 | PE167.6x | E35.8% | 4.7% | ||
GEKA | Mex$0.89 | 8.5% | 19.5% | Mex$15.5b | Mex$1.10 | PE14.8x | E26.7% | 4.7% | ||
UTH | US$221.00 | 1.4% | 6.3% | US$11.2b | US$271.64 | PE11.2x | E7.5% | n/a | ||
IDP | US$203.20 | 11.8% | -27.3% | US$31.4b | US$270.50 | PE26.8x | E17.8% | n/a | ||
135A | US$1.67 | 24.4% | -39.7% | US$68.8m | US$6.30 | PE1x | E0.04% | n/a | ||
5EA | US$12.78 | -6.2% | n/a | US$6.5b | US$17.24 | PS1.5x | E89.1% | n/a | ||
2M7C | HK$0.81 | -1.2% | -42.9% | HK$17.1b | HK$1.25 | PE6.6x | E6.8% | 6.0% | ||
MRK | €148.00 | -4.1% | -10.3% | €64.8b | €180.84 | PE22.9x | E9.9% | 1.5% | ||
RIG2 | Ft23.52 | 4.5% | 8.6% | Ft1.7t | Ft29.39 | PE10.7x | E17.0% | 4.5% | ||
EXK | US$54.61 | -6.3% | -5.9% | US$10.8b | US$82.23 | PS4.4x | E61.9% | n/a | ||
JNJ | US$136.36 | -2.6% | -8.7% | US$353.8b | US$163.72 | PE18.2x | E5.1% | 3.4% | ||
29A | US$38.75 | 4.1% | 16.0% | US$2.1b | US$58.81 | PE14.7x | E19.0% | n/a |